Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-22T07:36:46.399Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment of Pica Behavior with Olanzapine

Published online by Cambridge University Press:  07 November 2014

Alan Jay Lerner
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Communique
Information
CNS Spectrums , Volume 13 , Issue 1 , January 2008 , pp. 19
Copyright
Copyright © Cambridge University Press 2008

References

REFERENCES

1.McAdam, DB, Sherman, JA, Sheldon, JB, et al.Behavioral interventions to reduce the pica of persons with developmental disabilities. Behav Modif. 2004;28:45–72.CrossRefGoogle ScholarPubMed
2.Frey, AS, McKee, M, King, RA, Martin A Hair apparent: Rapunzel syndrome. Am J Psychiatry. 2005;162:242–248.CrossRefGoogle ScholarPubMed
3.Gundogar, D, Demir, SB, Eren, I. Is pica in the spectrum of obsessive-compulsive disorder? Gen Hosp Psychiatry. 2003;25:293–294.CrossRefGoogle Scholar
4.Madden, LJ, Seeley, RJ, Woods, SC. Intraventricular neuropeptide Y decreases need-induced sodium appetite and increases pica in rats. Behav Neurosci. 1999;113:826–832.CrossRefGoogle ScholarPubMed
5.Lhermitte, F. ‘Utilization behaviour’ and its relation to lesions of the frontal lobes. Brain. 1983,106:237–255.CrossRefGoogle ScholarPubMed
6.Archibald, SJ, Mateer, CA, Kerns, KA. Utilization behavior: clinical manifestations and neurological mechanisms. Neuropsychol Rev. 2001;11:117–130.CrossRefGoogle ScholarPubMed
7.Tollefson, GD, Sanger, TM. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine. Am JPsychiatry. 1997;154:466–474.Google ScholarPubMed